A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma

This publication has 13 references indexed in Scilit:

• Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)
  American Journal of Obstetrics and Gynecology, 1983
• A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma
  Cancer, 1983
• cis-platinum, adriamycin, and hexamethylmelamine versus cyclophosphamide in advanced ovarian carcinoma
  Cancer Chemotherapy and Pharmacology, 1983
• Phase II trial of amsacrine (m-AMSA) in advanced ovarian carcinoma
  European Journal of Cancer and Clinical Oncology, 1982
• Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)
  Cancer, 1981
• Epithelial Carcinoma of the Ovary: Current Strategies
  Annals of Internal Medicine, 1981
• Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin
  Cancer, 1980
• Low-dose cyclophosphamide versus adriamycin plus cyclophosphamide in advanced ovarian cancer
  Cancer Chemotherapy and Pharmacology, 1980
• Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with treosulfan (=dihydroxybusulfan)
  Cancer, 1980
• Management of Ovarian Carcinoma
  New England Journal of Medicine, 1976